Insights into migraine patient characteristics and treatment patterns: Interim baseline results from the TReatment of mIgraine: oUtcoMes for Patients in real-world Healthcare systems Europe (TRIUMPH [Europe]) study

被引：0
|
作者：
Patel, Niraj [1 ]
Novick, Diego [1 ]
Kennedy, Gina [2 ]
Martimianaki, Georgia [1 ]
Gabilondo, Hugo
Pozo-Rosich, Patricia [3 ,4 ]
机构：
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
[2] South Tyneside & Sunderland, South Tyneside & Sunderland NHS Fdn Trust, South Shields, England
[3] Vall dHebron Univ Hosp, Dept Neurol, Headache Unit, Barcelona, Spain
[4] Univ Autonoma Barcelona, Vall dHebron Inst Res VHIR, Dept Med, Headache & Neurol Pain ResearchGrp, Barcelona, Spain
来源：
CEPHALALGIA | 2023年 / 43卷 / 1supp期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
IHC23-IND-
引用
收藏
页码：67 / 68
页数：2
相关论文
共 50 条
  • [41] Understanding the real-world treatment patterns in patients using migraine preventive medications in Ontario, Canada
    Lay, Christine
    Lagman-Bartolome, Ana Marissa
    Rusu, Ana
    Awan, Amnah
    Shah-Manek, Bijal
    Barot, Purva
    Iconaru, Cristian
    Golden, Shane
    Tehrani, Ali
    Davidovic, Goran
    Millson, Brad
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 455
  • [42] Real-world evidence from a European cohort study of patients with treatment resistant depression: Baseline patient characteristics
    Heerlein, K.
    Young, A. H.
    Otte, C.
    Frodl, T.
    Degraeve, G.
    Hagedoorn, W.
    Oliveira-Maia, A. J.
    Sola, V. Perez
    Rathod, S.
    Rosso, G.
    Sierra, P.
    Morrens, J.
    Dooren, G. Van
    Gali, Y.
    Perugi, G.
    JOURNAL OF AFFECTIVE DISORDERS, 2021, 283 : 115 - 122
  • [43] A Real-World Analysis of Migraine: A Cross-Sectional Study of Disease Burden and Treatment Patterns
    Ford, Janet H.
    Jackson, James
    Milligan, Gary
    Cotton, Sarah
    Ahl, Jonna
    Aurora, Sheena K.
    HEADACHE, 2017, 57 (10): : 1532 - 1544
  • [44] Real-world data on reductions in migraine and headache days with fremanezumab treatment for US patients with chronic and episodic migraine: Results from a physician chart review study
    Cohen, J. M.
    Thompson, S. F.
    Patterson-Lomba, O.
    Driessen, M. T.
    Seminerio, M. J.
    Carr, K.
    Mu, F.
    HEADACHE, 2021, 61 : 70 - 71
  • [45] Real-world treatment experience and satisfaction among migraine patients: A descriptive survey study
    Smith, T. R.
    Hubig, L.
    Williams, E.
    Litalien, G. J.
    Harris, L.
    Powell, L. C.
    Johnson, K. M.
    Coric, V.
    Lloyd, A.
    Lo, S.
    HEADACHE, 2022, 62 : 82 - 83
  • [46] Effectiveness of Galcanezumab vs. Traditional Oral Migraine Preventive Medications: Interim 3-Month Results from Real-World TRIUMPH Study
    Lipton, R.
    Lainez, M.
    Ahmed, Z.
    Kurth, T.
    Vincent, M.
    Novick, D.
    Vallarino, C.
    Viktrup, L.
    Robinson, R.
    HEADACHE, 2023, 63 : 129 - 130
  • [47] Effectiveness of galcanezumab vs. traditional oral migraine preventive medications: interim 3-Month results from real-world TRIUMPH study
    Lipton, R. B.
    Lainez, M.
    Ahmed, Z.
    Kurth, T.
    Vincent, M.
    Novick, D.
    Vallarino, C.
    Viktrup, L.
    Robinson, R. L.
    JOURNAL OF HEADACHE AND PAIN, 2024, 25
  • [48] Final results of the SPECTRE study: real-world data giving an insight into the treatment of migraine patients with erenumab in Germany
    Gaul, Charly
    Koch, Mirja
    Weiss, Cordula
    NEUROLOGY, 2023, 100 (17)
  • [49] A Real-world analysis of the burden of migraine in patients with prior treatment failure: evidence from the BECOME study
    Lucas, C.
    Pozo-Rosich, P.
    Watson, D.
    Gaul, C.
    Ramsden, E.
    Ritter, S.
    Martelletti, P.
    Snellman, J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 801 - 801
  • [50] A Real-World Analysis of the Burden of Migraine in Patients with Prior Treatment Failure: Evidence from the BECOME Study
    Lucas, Christian
    Pozo-Rosich, Patricia
    Watson, David P. B.
    Gaul, Charly
    Ramsden, Emma
    Ritter, Shannon
    Martelletti, Paolo
    Snellman, Josefin
    CEPHALALGIA, 2019, 39 : 111 - 112
12345